May 12, 2017 Is International ME/CFS and FM Awareness Day
International ME/CFS and FM Awareness Day is May 12th, 2017. Jody Smith shares some information about upcoming events and ways you can be heard ...
Discuss the article on the Forums.

Ruxolitinib (JAK1 JAK2 inhibitor): remarking results on intestinal inflammation

Discussion in 'Other Health News and Research' started by Aubry, Nov 2, 2017.

  1. Aubry

    Aubry Senior Member

    Messages:
    139
    Likes:
    161
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854652/#!po=31.3333

    C respresents inflamed dentric cells of the gut before and after administration of Ruxolitinib (the purple grapes are inflamed cells). This is causing probably the abnormalities seen in the micro biome of all ME/CFS patients.Since the micro biome is more and more investigated this could be very interesting for ME/CFS as well. Prof. Meirleir will start trials in 2018 with Filgotinib (another JAK inhibitor) in his patient groups.


    Skin and intestinal GvHD responds to ruxolitinib
    [​IMG]
     

    Attached Files:

    • C.jpg
      C.jpg
      File size:
      72.7 KB
      Views:
      1
    Twazzle, unicorn7, ErdemX and 4 others like this.
  2. knackers323

    knackers323 Senior Member

    Messages:
    1,396
    Likes:
    423
    This looks good. Following
     
  3. jaybee00

    jaybee00 Senior Member

    Messages:
    105
    Likes:
    125
  4. tyson oberle

    tyson oberle Senior Member

    Messages:
    113
    Likes:
    72
    tampa, florida
     
  5. tyson oberle

    tyson oberle Senior Member

    Messages:
    113
    Likes:
    72
    tampa, florida
    So did Dr De Meirleir start trials yet with Filgotinib?
     

See more popular forum discussions.

Share This Page